Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon B Mills

Showing results (111-120 of 826) with videos related to

Pageof 83
Sort By:
Nature Reviews. Drug Discovery|December 13, 2005
Exploiting the PI3K/AKT pathway for cancer drug discoveryBryan T Hennessy, Debra L Smith, Prahlad T Ram, et al.
Cell|April 17, 2026
Targeting genomic instability in cancerTimothy A Yap, H Charles Manning, Puja Sapra, et al.
Molecular Oncology|March 23, 2013
EVI1 splice variants modulate functional responses in ovarian cancer cellsPunashi Dutta, Tuyen Bui, Kyle A Bauckman, et al.
Molecular Cancer Therapeutics|December 17, 2002
Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivoVictor M Bondar, Bridget Sweeney-Gotsch, Michael Andreeff, et al.
Journal of Medicinal Chemistry|December 12, 2003
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activityLian Qian, Yong Xu, Yutaka Hasegawa, et al.
Plos One|November 9, 2013
CanDrA: cancer-specific driver missense mutation annotation with optimized featuresYong Mao, Han Chen, Han Liang, et al.
Expert Review of Quality of Life in Cancer Care|March 26, 2019
The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancerLarissa Meyer, Rudy Suidan, Charlotte Sun, et al.
Trends in Biochemical Sciences|June 27, 2018
Gene Regulatory Network Perturbation by Genetic and Epigenetic VariationYongsheng Li, Daniel J McGrail, Juan Xu, et al.
Translational Oncology|July 12, 2020
Candidate biomarker assessment for pharmacological responseWilliam C Reinhold, Fathi Elloumi, Sudhir Varma, et al.
NPJ Breast Cancer|June 27, 2017
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Pageof 83

Showing results (111-120 of 826) with videos related to

Sort By:
Pageof 83
Nature Reviews. Drug Discovery|December 13, 2005
Exploiting the PI3K/AKT pathway for cancer drug discoveryBryan T Hennessy, Debra L Smith, Prahlad T Ram, et al.
Cell|April 17, 2026
Targeting genomic instability in cancerTimothy A Yap, H Charles Manning, Puja Sapra, et al.
Molecular Oncology|March 23, 2013
EVI1 splice variants modulate functional responses in ovarian cancer cellsPunashi Dutta, Tuyen Bui, Kyle A Bauckman, et al.
Molecular Cancer Therapeutics|December 17, 2002
Inhibition of the phosphatidylinositol 3'-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivoVictor M Bondar, Bridget Sweeney-Gotsch, Michael Andreeff, et al.
Journal of Medicinal Chemistry|December 12, 2003
Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activityLian Qian, Yong Xu, Yutaka Hasegawa, et al.
Plos One|November 9, 2013
CanDrA: cancer-specific driver missense mutation annotation with optimized featuresYong Mao, Han Chen, Han Liang, et al.
Expert Review of Quality of Life in Cancer Care|March 26, 2019
The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancerLarissa Meyer, Rudy Suidan, Charlotte Sun, et al.
Trends in Biochemical Sciences|June 27, 2018
Gene Regulatory Network Perturbation by Genetic and Epigenetic VariationYongsheng Li, Daniel J McGrail, Juan Xu, et al.
Translational Oncology|July 12, 2020
Candidate biomarker assessment for pharmacological responseWilliam C Reinhold, Fathi Elloumi, Sudhir Varma, et al.
NPJ Breast Cancer|June 27, 2017
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Pageof 83